Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Julien Roux
    Member
    • Dec 2011
    • 24

    #1

    DEXSeq gene level counts

    Dear DEXSeq authors,
    I have a question related to the following paragraph in the DEXSeq vignette:
    Note that a read that mapped to several exons of a gene is counted for each of these exons by the dexseq_count.py script. The table returned geneCountTable will hence count the read several time for the gene, which may skew downstream analyses in subtle ways. Hence, we recommend to use geneCountTable with care and use more sophisticated counting schemes where appropriate.
    I am wondering if this problem is also affecting the tests for differential expression of exons in DEXSeq? I have the feeling that the reads overlapping multiple exons are also counted several times when it comes to estimate gene expression levels (to control for overall differences in expression at the gene level when testing exons). Is this accounted for in the package functions?

    Thanks for your help
    Julien
  • Simon Anders
    Senior Member
    • Feb 2010
    • 995

    #2
    It's not really an issue because if a gene is expressed more strongle in one sample than in another, all exon counts, including those that result from double-counting due to overlaps, will be scaled up in a proportional manner, so that the expression ratio between the samples is still estimated correctly.

    Comment

    • Julien Roux
      Member
      • Dec 2011
      • 24

      #3
      Hi Simon,
      Thanks for your answer. However I am not fully convinced that it is not an issue...

      In my dataset at least 40% of the reads overlap an exon junction. If you count these read twice when estimating gene baseline levels, it can lead to major estimation errors for the expression ratio between conditions (especially when there is a large difference between conditions).

      An easy fix would be to provide DEXSeq the correct gene count table. Is there a way to do this and use it in the function "testGeneForDEU"?
      Thanks for your help
      Julien
      Last edited by Julien Roux; 11-27-2012, 03:03 PM.

      Comment

      • Simon Anders
        Senior Member
        • Feb 2010
        • 995

        #4
        As DEXSeq performs a hypothesis test, we only need to ensure that the "null" case is not affected. The null hypothesis in DEXSeq is that the relative proportions that the differnt isoforms contribute to overall gene expression does not depend on the condition, while the overall expression strength may change.

        If now a gene is expressed twice as strongly in one condition than in the other, all per-exon counts go up by a factor of two. The number of reads that fall onto two exons goes up by two, as well, so that the ratio of each per-exon count to the sum of all per-exon counts stays as constant. This is all that we need. There is no need for the sum of all per-exon counts to reflect gene expression strength faithfully.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...